Atai backs away from schizophrenia drug after trial failure

The company plans to direct resources away from a drug developed by subsidiary Recognify Life Sciences and toward Atai’s wholly owned, psychedelics-focused pipeline.

Religious leaders, media executives seek ethical AI framework – EnviroNews

February 16, 2026

Customs intercepts four live Pangolins in Ogun – EnviroNews

February 16, 2026

Source link

Atai backs away from schizophrenia drug after trial failure

Religious leaders, media executives seek ethical AI framework – EnviroNews

Customs intercepts four live Pangolins in Ogun – EnviroNews

Top African VC Funds Actively Investing Right Now (2025 Update)

Social housing and the future of Cape Town’s inner-city

Social housing and the future of Cape Town’s inner-city

Leave a Reply Cancel reply

RECOMMENDED NEWS

AI tool aims to improve expert decision-making accuracy

MSC’s Luxury “Ship Within a Ship” Yacht Club Experience Is Coming to Galveston

The Sweeping Danger of the AT&T Phone Records Breach

Naturepedic Promo Codes and Deals: 20% Off

POPULAR NEWS

Ghana to build three oil refineries, five petrochemical plants in energy sector overhaul

The world’s top 10 most valuable car brands in 2025

Top 10 African countries with the highest GDP per capita in 2025

Global ranking of Top 5 smartphone brands in Q3, 2024

When Will SHIB Reach $1? Here’s What ChatGPT Says

Atai backs away from schizophrenia drug after trial failure

Related posts

Top African VC Funds Actively Investing Right Now (2025 Update)

Social housing and the future of Cape Town’s inner-city

Leave a Reply Cancel reply

RECOMMENDED NEWS

POPULAR NEWS